NETs activate the GAS6-AXL-NLRP3 axis in macrophages to drive morphine tolerance

Qingyan Tian1, Haiyue Guo1, Mengyao Zhang1

  • 1Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.

Abstract

Insights

Neutrophil extracellular traps (NETs) drive morphine tolerance by activating the GAS6-AXL-TLR7/9 pathway. Disrupting NETs or this axis offers a novel strategy to manage pain effectively.

Area of Science:

  • Immunology
  • Pharmacology
  • Pain Research

Background:

  • Morphine tolerance is a significant clinical obstacle in managing severe pain.
  • Understanding the molecular mechanisms of morphine tolerance is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of neutrophil extracellular traps (NETs) in the development of morphine tolerance.
  • To elucidate the specific molecular pathways involved in NETs-mediated morphine tolerance.
  • To identify potential therapeutic targets for combating morphine tolerance.

Main Methods:

  • Evaluation of morphine tolerance in C57BL/6J mice using the tail-flick test.
  • Investigation of NETs formation and macrophage engulfment via Western blotting, real-time PCR, ELISA, and confocal microscopy.
  • Assessment of the GAS6-AXL-TLR7/9-NLRP3 inflammasome pathway and cytokine production (IL-1β, IL-18).

Main Results:

  • Elevated NETs levels were observed in patients and animals experiencing morphine tolerance.
  • Genetic or pharmacological disruption of NETs formation significantly alleviated morphine tolerance.
  • Morphine-induced NETs are engulfed by macrophages via the GAS6-AXL axis, activating the TLR7/9-NLRP3 inflammasome and increasing IL-1β/IL-18, contributing to tolerance.
  • Targeting components of this pathway (Axl, Gas6, Nlrp3) or using IL-1 receptor antagonist (anakinra) or IL-18BP ameliorated morphine tolerance.

Conclusions:

  • Morphine-induced NETs are a critical factor in the development of analgesic tolerance.
  • The GAS6-AXL-TLR7/9 signaling axis represents a novel therapeutic target for overcoming morphine tolerance.
  • Interventions aimed at disrupting NETs or modulating this axis hold promise for improving pain management strategies.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
402
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
346
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
142
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
181
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.6K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.6K